ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļRMD
āļāļ·āđāļāļāļĢāļīāļĐāļąāļResmed Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 01, 1995
āļāļĩāļāļĩāđāļFarrell (Michael J)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ10600
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJun 01
āļāļĩāđāļāļĒāļđāđ9001 Spectrum Center Blvd
āđāļĄāļ·āļāļSAN DIEGO
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ92123
āđāļāļĢāļĻāļąāļāļāđ18587462400
āđāļ§āđāļāđāļāļāđhttps://www.resmed.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļRMD
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 01, 1995
āļāļĩāļāļĩāđāļFarrell (Michael J)
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
Ms. Carol J. Burt
Independent Director
Ms. Harjit Gill
Independent Director
Ms. Karen Drexler
Independent Director
Dr. Desney Tan
Independent Director
Dr. Peter C. Farrell, Ph.D.
Dr. Peter C. Farrell, Ph.D.
Founder and Chairman Emeritus
Founder and Chairman Emeritus
Mr. Brett A. Sandercock
Chief Financial Officer
Mr. Jan De Witte
Independent Director
Mr. Justin M. W. Leong
Chief Product Officer
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
Ms. Carol J. Burt
Independent Director
Ms. Harjit Gill
Independent Director
Ms. Karen Drexler
Independent Director
Dr. Desney Tan
Independent Director
Langar Global HealthTech ETF
First Trust Nasdaq Lux Digi Health Solutions ETF
Pacer US Cash Cows Growth ETF
iShares U.S. Medical Devices ETF
ERShares Entrepreneurs ETF
Siren DIVCON Dividend Defender ETF
SEI Enhanced US Large Cap Quality Factor ETF
First Trust Growth Strength ETF
First Trust Indxx Medical Devices ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Langar Global HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ9.06%
First Trust Nasdaq Lux Digi Health Solutions ETF
āļŠāļąāļāļŠāđāļ§āļ7.21%
Pacer US Cash Cows Growth ETF
āļŠāļąāļāļŠāđāļ§āļ4.31%
iShares U.S. Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ4.09%
Global X HealthTech ETF
āļŠāļąāļāļŠāđāļ§āļ4.02%
ERShares Entrepreneurs ETF
āļŠāļąāļāļŠāđāļ§āļ2.49%
Siren DIVCON Dividend Defender ETF
āļŠāļąāļāļŠāđāļ§āļ2.22%
SEI Enhanced US Large Cap Quality Factor ETF
āļŠāļąāļāļŠāđāļ§āļ1.92%
First Trust Growth Strength ETF
āļŠāļąāļāļŠāđāļ§āļ1.83%
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ1.82%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
1.32B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
RMD.NB Interim Cash Dividend of gross USD 0.6 paid on Mar 19, 2026 going ex on Feb 12, 2026
RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 20, 2025 going ex on Feb 13, 2025
RMD.NB Interim Cash Dividend of gross USD 0.53 paid on Dec 12, 2024 going ex on Nov 07, 2024
RMD.NB Final Cash Dividend of gross USD 0.53 paid on Sep 19, 2024 going ex on Aug 15, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Jun 13, 2024 going ex on May 08, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Mar 14, 2024 going ex on Feb 07, 2024
RMD.NB Interim Cash Dividend of gross USD 0.48 paid on Dec 14, 2023 going ex on Nov 08, 2023
RMD.NB Final Cash Dividend of gross USD 0.48 paid on Sep 21, 2023 going ex on Aug 16, 2023
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Jun 15, 2023 going ex on May 10, 2023
RMD.NB Interim Cash Dividend of gross USD 0.44 paid on Mar 16, 2023 going ex on Feb 08, 2023
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ